Skip to main content

Spectrum: Autism Research News

Author

Peter Hess

Former News Writer

Peter Hess was a reporter for Spectrum from 2019 to 2023, where he covered cannabinoids, autism prevalence, social hormones and other topics. Before joining Spectrum in 2019, he was associate science editor at Inverse, where he wrote and edited stories for a broad audience on a wide range of scientific topics, including drugs, evolution and environmental science. His work has also appeared in The Washington PostNew ScientistPopular Science and Motherboard. Peter has an M.A. in science journalism from New York University’s Science, Health and Environmental Reporting Program. Find him on Twitter at @PeterNHess.

October 2021

Rising star: Brian Lee pushes the limits of autism epidemiology

by  /  14 October 2021

Brian Lee has transformed the science of linking prenatal experiences to a child’s chances of having autism; his work taps social skills as well as statistical acumen.

Comments
Mayada Elsabbagh portrait in her messy kitchen, drinking coffee.

Beyond the bench: A conversation with Mayada Elsabbagh

by  /  13 October 2021

Mayada Elsabbagh talks about her “neurotic scheduling” (and its limits), why she is not active on social media, and her lab’s cookie time.

Comments

Society for Neuroscience reverses refund policy for in-person conference registrants

by  /  11 October 2021

Those who no longer wish to attend the virtual meeting of the Society for Neuroscience (SfN) can request registration fee refunds, SfN announced after a social media outcry.

Comments
Empty conference hall in blue light.

Society for Neuroscience cancels in-person meeting

The decision comes after a Spectrum survey found that most autism researchers did not plan to attend in person.

Comments
Two colorful mouse neurons seen side by side on black, one has a mutation.

Precocious neurons may stunt brain growth in rare form of autism

by  /  5 October 2021

The first animal model of MYT1L syndrome suggests that fast-maturing neurons lead to the unusually small brains, social deficits and other traits seen in people with the condition.

Comments
Closeup photo of a liquid being poured out of a brown bottle.

French pharma firms terminate trials of bumetanide for autism

by  /  1 October 2021

Preliminary results suggested the treatment is no better than placebo at reducing the severity of core autism traits.

Comments
September 2021
Week of SeptemberSep
20th
2021

Spotted around the web: Parental age, autism-schizophrenia overlap, bumetanide trials

by , , ,  /  24 September 2021

Here is a roundup of news and research for the week of 20 September.

Comments
Mother and child playing with small colored blocks on the carpet.

Uncertainty clouds test of ‘preemptive’ therapy to ease autism traits

by  /  24 September 2021

Experts question data showing that an experimental therapy that parents deliver to babies with early signs of autism can lessen the intensity of the children’s traits and lower their chances of diagnosis at age 3.

Comments
Child makes a row of flowers on the ground.

Repetitive behaviors wax and wane among autistic youth

by  /  20 September 2021

Some types of restricted and repetitive behaviors become more prevalent among autistic children and teenagers over time, depending on their age and intellectual ability, whereas others decrease.

Comments
Playful chart in red and blue patterns

By the Numbers: Machine learning, dementia link, antipsychotics while pregnant

by ,  /  16 September 2021

In this edition of By the Numbers, we discuss machine learning for autism, early-onset dementia, and antipsychotic medicines during pregnancy.

Comments